An overview of Indian pharmaceutical formulation and manufacturing operations, specializing in advanced oncology delivery systems including 20 mg liposomal doxorubicin. The facilities operate under certified cGMP and WHO-GMP standards, supporting international regulatory compliance and bulk healthcare supply. https://unitedbiotechindia.com/